VVOS - Biotech Soars On New Agreements
2023-10-04 15:36:45 ET
A Colorado-based healthcare company is finding tremendous success so far on Tuesday after the company announced strategic agreements to expand its current product line and create new revenue opportunities.
Shares of %VivosTherapeutics (Nasdaq: ) soared on the news, topping out at $0.4498/share (+143.14%) at the session high. This move came on massive relative volume, so it could be an indication of things to come!
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists.
About AllPennyStocks.com Media Inc.:
AllPennyStocks.com Media, Inc., founded in 1999, is one of North America’s largest and most comprehensive small-cap / penny stock financial portals. With Canadian and U.S. focused penny stock features and content, the site offers information for novice investors to expert traders.